My bill delivers the regulatory certainty manufacturers need to innovate and invest with confidence, while establishing transparency and predictability within the drug preclusion framework and preserving consumer access to dietary supplements.
Pass the Dietary Supplement Innovation Act to modernize FDA drug preclusion rules, create clearer and more transparent standards, protect longstanding dietary supplement ingredients, and preserve consumer access to dietary supplements.
Occurrences
Action Mrs. Harshbarger introduced the following bill; which was referred to the Committee on Energy and Commerce Bill Number H.R. 10336 Bill Version Introduced in House (IH) Short Title Dietary Supplement Innovation Act Full Title To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.
Evidence
verified · Source version 70945 · locator 1263
Mrs. Harshbarger introduced the following bill; which was referred to the Committee on Energy and Commerce
verified · Source version 70957 · locator 1091
This Act may be cited as the ``Dietary Supplement Innovation Act''.
verified · Source version 70959 · locator 3895
H.R. 10336. A bill to amend the Federal Food, Drug, and Cosmetic Act
verified · Source version 70961 · locator 3766
today introduced the Dietary Supplement Innovation Act, legislation that modernizes the Food and Drug Administration’s (FDA) drug preclusion provision
Assessments
The commitment is to pass or achieve the Dietary Supplement Innovation Act’s regulatory changes, not merely introduce the bill. Verified evidence shows Harshbarger introduced H.R. 10336 and that it was referred to the House Committee on Energy and Commerce, with bill text matching the Dietary Supplement Innovation Act, but no verified passage shows enactment or implementation by the as_of_date. Because there is documented candidate effort but no enacted outcome and no expired deadline, the promise remains unresolved.